Both in Pharmaceuticals
Biofrontera vs Bolt Biotherapeutics
Over the past year BFRI returned −18.2% and BOLT returned +1.9%; their daily moves had a correlation of 0.05.
BFRI −18.2% BOLT +1.9%Growth of $1, one year, split-adjusted
| Metric | BFRI | BOLT |
|---|---|---|
| Price | $0.8386 | $6.36 |
| Market cap | $12.5M | $15.0M |
| Today | +2.02% | −3.49% |
| 1 month | −25.8% | +83.8% |
| 6 months | −25.1% | +31.4% |
| Year to date | +47.1% | +16.3% |
| 1 year | −23.8% | +6.0% |
| Revenue growth (YoY) | +32.9% | −99.7% |
| Gross margin | 79.9% | 100.0% |
| Net margin | −5.0% | −154400.0% |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | 3.2× |
| Net cash | $47.0K | $17.6M |
| Dividend yield | — | — |
| Volatility (60d) | 73.9% | 111.2% |
| Short % of float | 0.9% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).